Literature DB >> 23184794

3D porous chitosan-alginate scaffolds: a new matrix for studying prostate cancer cell-lymphocyte interactions in vitro.

Stephen J Florczyk1, Gang Liu, Forrest M Kievit, Allison M Lewis, Jennifer D Wu, Miqin Zhang.   

Abstract

The treatment of castration-resistant prostate cancer (CRPC) remains palliative. Immunotherapy offers a potentially effective therapy for CRPC; however, its advancement into the clinic has been slow, in part because of the lack of representative in vitro tumor models that resemble the in vivo tumor microenvironment for studying interactions of CRPC cells with immune cells and other potential therapeutics. This study evaluates the use of 3D porous chitosan-alginate (CA) scaffolds for culturing human prostate cancer (PCa) cells and studying tumor cell interaction with human peripheral blood lymphocytes (PBLs) ex vivo. CA scaffolds and Matrigel matrix samples support in vitro tumor spheroid formation over 15 d of culture, and CA scaffolds support live-cell fluorescence imaging with confocal microscopy using stably transfected PCa cells for 55 d. PCa cells grown in Matrigel matrix and CA scaffolds for 15 d are co-cultured with PBLs for 2 and 6 d in vitro and evaluated with scanning electron microscopy (SEM), immunohistochemistry (IHC), and flow cytometry. Both the Matrigel matrix and CA scaffolds support interaction of PBLs with PCa tumors, with CA scaffolds providing a more robust platform for subsequent analyses. This study demonstrates the use of 3D natural polymer scaffolds as a tissue culture model for supporting long-term analysis of interaction of prostate cancer tumor cells with immune cells, providing an in vitro platform for rapid immunotherapy development.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Year:  2012        PMID: 23184794      PMCID: PMC3682216          DOI: 10.1002/adhm.201100054

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  44 in total

Review 1.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering.

Authors:  M P Lutolf; J A Hubbell
Journal:  Nat Biotechnol       Date:  2005-01       Impact factor: 54.908

2.  Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis.

Authors:  Muhammad H Zaman; Linda M Trapani; Alisha L Sieminski; Alisha Siemeski; Drew Mackellar; Haiyan Gong; Roger D Kamm; Alan Wells; Douglas A Lauffenburger; Paul Matsudaira
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

Review 3.  Adoptive immunotherapy for cancer: building on success.

Authors:  Luca Gattinoni; Daniel J Powell; Steven A Rosenberg; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

4.  Inhibitory effect of tumor cell-derived lactic acid on human T cells.

Authors:  Karin Fischer; Petra Hoffmann; Simon Voelkl; Norbert Meidenbauer; Julia Ammer; Matthias Edinger; Eva Gottfried; Sabine Schwarz; Gregor Rothe; Sabine Hoves; Kathrin Renner; Birgit Timischl; Andreas Mackensen; Leoni Kunz-Schughart; Reinhard Andreesen; Stefan W Krause; Marina Kreutz
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

5.  Three-dimensional culture models of normal and malignant breast epithelial cells.

Authors:  Genee Y Lee; Paraic A Kenny; Eva H Lee; Mina J Bissell
Journal:  Nat Methods       Date:  2007-04       Impact factor: 28.547

6.  Hyaluronan stimulates transformation of androgen-independent prostate cancer.

Authors:  Shi-Lung Lin; Donald Chang; Shao-Yao Ying
Journal:  Carcinogenesis       Date:  2006-07-24       Impact factor: 4.944

Review 7.  Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.

Authors:  R E Sobel; M D Sadar
Journal:  J Urol       Date:  2005-02       Impact factor: 7.450

8.  Engineering tumors with 3D scaffolds.

Authors:  Claudia Fischbach; Ruth Chen; Takuya Matsumoto; Tobias Schmelzle; Joan S Brugge; Peter J Polverini; David J Mooney
Journal:  Nat Methods       Date:  2007-09-02       Impact factor: 28.547

9.  New dimensions in tumor immunology: what does 3D culture reveal?

Authors:  Chantal Feder-Mengus; Sourabh Ghosh; Anca Reschner; Ivan Martin; Giulio C Spagnoli
Journal:  Trends Mol Med       Date:  2008-07-07       Impact factor: 11.951

10.  Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes.

Authors:  C Feder-Mengus; S Ghosh; W P Weber; S Wyler; P Zajac; L Terracciano; D Oertli; M Heberer; I Martin; G C Spagnoli; A Reschner
Journal:  Br J Cancer       Date:  2007-03-06       Impact factor: 7.640

View more
  26 in total

Review 1.  Biomaterials and emerging anticancer therapeutics: engineering the microenvironment.

Authors:  Luo Gu; David J Mooney
Journal:  Nat Rev Cancer       Date:  2016-01       Impact factor: 60.716

2.  Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM.

Authors:  Stephen J Florczyk; Kui Wang; Soumen Jana; David L Wood; Samara K Sytsma; Jonathan Sham; Forrest M Kievit; Miqin Zhang
Journal:  Biomaterials       Date:  2013-09-26       Impact factor: 12.479

3.  Modeling the tumor microenvironment using chitosan-alginate scaffolds to control the stem-like state of glioblastoma cells.

Authors:  Forrest M Kievit; Kui Wang; Ariane E Erickson; Sheeny K Lan Levengood; Richard G Ellenbogen; Miqin Zhang
Journal:  Biomater Sci       Date:  2015-12-21       Impact factor: 6.843

Review 4.  Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models.

Authors:  Mariana R Carvalho; Daniela Lima; Rui L Reis; Joaquim M Oliveira; Vitor M Correlo
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

5.  3d Tissue Engineered In Vitro Models Of Cancer In Bone.

Authors:  Anna M Sitarski; Heather Fairfield; Carolyne Falank; Michaela R Reagan
Journal:  ACS Biomater Sci Eng       Date:  2017-06-09

Review 6.  Microfluidic models for adoptive cell-mediated cancer immunotherapies.

Authors:  Giulia Adriani; Andrea Pavesi; Anthony T Tan; Antonio Bertoletti; Jean Paul Thiery; Roger D Kamm
Journal:  Drug Discov Today       Date:  2016-05-13       Impact factor: 7.851

7.  Proliferation and enrichment of CD133(+) glioblastoma cancer stem cells on 3D chitosan-alginate scaffolds.

Authors:  Forrest M Kievit; Stephen J Florczyk; Matthew C Leung; Kui Wang; Jennifer D Wu; John R Silber; Richard G Ellenbogen; Jerry S H Lee; Miqin Zhang
Journal:  Biomaterials       Date:  2014-08-07       Impact factor: 12.479

8.  3D Porous Chitosan-Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer.

Authors:  Kui Wang; Forrest M Kievit; Stephen J Florczyk; Zachary R Stephen; Miqin Zhang
Journal:  Biomacromolecules       Date:  2015-09-16       Impact factor: 6.988

9.  Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cells.

Authors:  Vy Phan-Lai; Stephen J Florczyk; Forrest M Kievit; Kui Wang; Ekram Gad; Mary L Disis; Miqin Zhang
Journal:  Biomacromolecules       Date:  2013-04-03       Impact factor: 6.988

10.  Chitosan-based thermoreversible hydrogel as an in vitro tumor microenvironment for testing breast cancer therapies.

Authors:  Ching-Ting Tsao; Forrest M Kievit; Kui Wang; Ariane E Erickson; Richard G Ellenbogen; Miqin Zhang
Journal:  Mol Pharm       Date:  2014-05-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.